{"id":19657,"date":"2024-04-15T14:45:32","date_gmt":"2024-04-15T18:45:32","guid":{"rendered":"https:\/\/aafa.org\/?p=19657"},"modified":"2024-06-25T17:23:46","modified_gmt":"2024-06-25T21:23:46","slug":"digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma","status":"publish","type":"post","link":"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/","title":{"rendered":"Digihaler Discontinuation May Cause Another Disruption in Care for People with Asthma"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”News T-Hero Section” module_class=”hero tert” _builder_version=”4.18.0″ _module_preset=”default” background_image=”https:\/\/aafa.org\/wp-content\/uploads\/2022\/07\/AAFA-Website_Tertiary_News.jpg” background_position=”top_right” custom_padding=”1%||1%||true|false” global_module=”2297″ saved_tabs=”all” collapsed=”on” global_colors_info=”{}”][et_pb_row _builder_version=”4.17.4″ _module_preset=”default” background_enable_image=”off” background_size=”initial” background_position=”bottom_left” background_horizontal_offset=”0%” custom_margin=”||||false|false” custom_padding=”2%||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”Nav Parent Title” module_class=”tert-parent” _builder_version=”4.20.4″ _module_preset=”default” header_2_font=”|600|||||||” header_2_text_align=”left” header_2_text_color=”#FFFFFF” header_2_font_size=”32px” custom_margin=”||0px||false|false” global_colors_info=”{}”]<\/p>\n

News<\/h2>\n

[\/et_pb_text][et_pb_code admin_label=”Breadcrumbs” module_class=”bcrumb” _builder_version=”4.17.4″ _module_preset=”default” text_orientation=”left” custom_margin=”||||false|false” custom_padding=”||||false|false” custom_css_main_element=”font-size:16px;||color: #fff;” global_colors_info=”{}”][\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Main Content” _builder_version=”4.17.4″ _module_preset=”default” background_enable_image=”off” background_size=”initial” background_position=”bottom_right” custom_padding=”2%||2%||true|false” collapsed=”off” global_colors_info=”{}”][et_pb_row admin_label=”Title Row” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_post_title author=”off” comments=”off” featured_image=”off” admin_label=”Blog Post Title” _builder_version=”4.18.0″ _module_preset=”default” title_level=”h2″ title_font=”|600|||||||” title_text_color=”#008C99″ title_font_size=”39px” meta_font=”|700|||||||” meta_text_color=”#505050″ meta_font_size=”20px” title_font_size_tablet=”30px” title_font_size_phone=”26px” title_font_size_last_edited=”on|phone” meta_font_size_tablet=”20px” meta_font_size_phone=”16px” meta_font_size_last_edited=”on|phone” global_colors_info=”{}”][\/et_pb_post_title][\/et_pb_column][\/et_pb_row][et_pb_row admin_label=”Content Row” module_class=”blog-single” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”Page Content” module_class=”secondary-intro” _builder_version=”4.24.2″ _module_preset=”default” text_text_color=”#505050″ text_line_height=”1.5em” header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” custom_margin=”||3%||false|false” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

AAFA urges patients to work with providers to find alternative treatment options<\/em><\/p>\n

\n

Washington, DC, April 15, 2024 \u2013 In response to news that drug manufacturer Teva plans to discontinue U.S. distribution of its Digihaler\u00ae products, the Asthma and Allergy Foundation of America issued the following statement which may be attributed to President and CEO Kenneth Mendez:<\/p>\n

\u201cIt is unfortunate to hear that more asthma inhalers are being discontinued,\u201d said Mendez. \u201cThe Teva Digihaler portfolio had offered an innovative approach to encourage adherence to treatment by integrating a digital solution with an inhaler. We hope manufacturers continue to invest in new asthma therapies.\u201d<\/p>\n

The products Teva discontinued include: ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler. Substitutes for both ProAir and AirDuo are available in Teva\u2019s Respiclick devices \u2013 the same medicine formulations and delivery devices without the digital component. Teva does not offer the ArmonAir formulation in either a branded or generic alternative. Mendez notes that people currently using Digihalers should start exploring alternatives now.<\/p>\n

\u201cIt is imperative that people using Teva\u2019s Digihaler products to treat their asthma reach out to their provider now to determine the best alternative treatment options. Unfortunately, when GSK discontinued Flovent, some people using that inhaler may have been transitioned to the ArmonAir Digihaler. Because some formularies do not cover the authorized generic of Flovent, the discontinuation of ArmonAir could mean patients are once again searching for an alternative treatment. Continuity of treatment is important for effective asthma care, and these frequent changes threaten to disrupt the efficacy of care received by some patients.\u201d<\/p>\n

A notice sent via email from Teva to health care providers says in part:<\/p>\n

On 6\/1\/2024 Teva will discontinue distribution of the Digihaler\u00ae products in the US [ProAir\u00ae Digihaler\u00ae (albuterol sulfate) Inhalation Powder, ArmonAir\u00ae Digihaler\u00ae (fluticasone propionate) Inhalation Powder, AirDuo\u00ae Digihaler\u00ae (fluticasone propionate and salmeterol) Inhalation Powder]. Software and technical support for the Digihaler app and dashboard will end on 6\/1\/2024<\/em>.<\/em><\/p>\n

To stay up to date on available asthma treatments, visit aafa.org\/asthma-medicine<\/a><\/p>\n

 <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row admin_label=”Content Row” module_class=”blog-single” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”Press Contact” _builder_version=”4.24.2″ _module_preset=”default” text_text_color=”#505050″ link_font=”||||on|||#008c99|” link_text_color=”#008c99″ header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” header_3_font=”|600|||||||” header_3_text_align=”left” header_3_text_color=”#008c99″ header_3_font_size=”28px” global_colors_info=”{}”]<\/p>\n

Press Contact:<\/strong>
Andy Spears
Asthma and Allergy Foundation of America (AAFA)
media@aafa.org<\/p>\n

[\/et_pb_text][et_pb_text admin_label=”About ” _builder_version=”4.24.2″ _module_preset=”default” text_text_color=”#505050″ link_font=”||||on|||#008c99|” link_text_color=”#008c99″ link_line_height=”1.7em” ul_line_height=”1.7em” header_2_font=”|600|||||||” header_2_text_color=”#008c99″ header_2_font_size=”39px” header_3_font=”|600|||||||” header_3_text_align=”left” header_3_text_color=”#008c99″ header_3_font_size=”28px” background_color=”#F5EDDF” custom_padding=”4%|4%|4%|4%|true|true” box_shadow_style=”preset2″ global_colors_info=”{}”]<\/p>\n

About AAFA<\/strong><\/p>\n

Founded in 1953, AAFA is the oldest and largest non-profit patient organization dedicated to saving lives and reducing the burden of disease for people with asthma, allergies, and related conditions through research, education, advocacy, and support. AAFA offers extensive support for individuals and families affected by asthma and allergic diseases, such as food allergies and atopic dermatitis (eczema). Through its online patient support communities, network of regional chapters, and collaborations with community-based groups, AAFA empowers patients and their families by providing practical, evidence-based information and community programs and services. AAFA is the only asthma and allergy patient advocacy group that is certified to meet the standards of excellence set by the National Health Council. For more information, visit:\u00a0aafa.org<\/a><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

NewsAAFA urges patients to work with providers to find alternative treatment options Washington, DC, April 15, 2024 \u2013 In response to news that drug manufacturer Teva plans to discontinue U.S. […]<\/p>\n","protected":false},"author":17,"featured_media":19659,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[32],"tags":[],"class_list":["post-19657","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-releases"],"acf":[],"yoast_head":"\nDigihaler Discontinuation May Cause Another Disruption in Care for People with Asthma - Asthma and Allergy Foundation of America<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Digihaler Discontinuation May Cause Another Disruption in Care for People with Asthma\" \/>\n<meta property=\"og:description\" content=\"NewsAAFA urges patients to work with providers to find alternative treatment options Washington, DC, April 15, 2024 \u2013 In response to news that drug manufacturer Teva plans to discontinue U.S. […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/\" \/>\n<meta property=\"og:site_name\" content=\"Asthma and Allergy Foundation of America\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-15T18:45:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-25T21:23:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aafa.org\/wp-content\/uploads\/2024\/04\/teva-digihaler-discontinuation-SM-jpg.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Asthma and Allergy Foundation of America (AAFA)\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Asthma and Allergy Foundation of America (AAFA)\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/aafa.org\\\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\\\/\"},\"author\":{\"name\":\"Asthma and Allergy Foundation of America (AAFA)\",\"@id\":\"https:\\\/\\\/aafa.org\\\/#\\\/schema\\\/person\\\/cf1763f0a1e69f5fa901f01d8e07c19b\"},\"headline\":\"Digihaler Discontinuation May Cause Another Disruption in Care for People with Asthma\",\"datePublished\":\"2024-04-15T18:45:32+00:00\",\"dateModified\":\"2024-06-25T21:23:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\\\/\"},\"wordCount\":1059,\"image\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/aafa.org\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/teva-digihaler-discontinuation-SM-jpg.webp\",\"articleSection\":[\"Press Release\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/aafa.org\\\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\\\/\",\"url\":\"https:\\\/\\\/aafa.org\\\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\\\/\",\"name\":\"Digihaler Discontinuation May Cause Another Disruption in Care for People with Asthma - Asthma and Allergy Foundation of America\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/aafa.org\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/teva-digihaler-discontinuation-SM-jpg.webp\",\"datePublished\":\"2024-04-15T18:45:32+00:00\",\"dateModified\":\"2024-06-25T21:23:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/#\\\/schema\\\/person\\\/cf1763f0a1e69f5fa901f01d8e07c19b\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/aafa.org\\\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/aafa.org\\\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/aafa.org\\\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/aafa.org\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/teva-digihaler-discontinuation-SM-jpg.webp\",\"contentUrl\":\"https:\\\/\\\/aafa.org\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/teva-digihaler-discontinuation-SM-jpg.webp\",\"width\":1080,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/aafa.org\\\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Press Release\",\"item\":\"https:\\\/\\\/aafa.org\\\/news\\\/press-releases\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Digihaler Discontinuation May Cause Another Disruption in Care for People with Asthma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/aafa.org\\\/#website\",\"url\":\"https:\\\/\\\/aafa.org\\\/\",\"name\":\"Asthma and Allergy Foundation of America\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/aafa.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/aafa.org\\\/#\\\/schema\\\/person\\\/cf1763f0a1e69f5fa901f01d8e07c19b\",\"name\":\"Asthma and Allergy Foundation of America (AAFA)\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f319ac743f2ee5f4b0bb04496f0f4185a171b28b586bf69b30337376fbd43e25?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f319ac743f2ee5f4b0bb04496f0f4185a171b28b586bf69b30337376fbd43e25?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f319ac743f2ee5f4b0bb04496f0f4185a171b28b586bf69b30337376fbd43e25?s=96&d=mm&r=g\",\"caption\":\"Asthma and Allergy Foundation of America (AAFA)\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Digihaler Discontinuation May Cause Another Disruption in Care for People with Asthma - Asthma and Allergy Foundation of America","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/","og_locale":"en_US","og_type":"article","og_title":"Digihaler Discontinuation May Cause Another Disruption in Care for People with Asthma","og_description":"NewsAAFA urges patients to work with providers to find alternative treatment options Washington, DC, April 15, 2024 \u2013 In response to news that drug manufacturer Teva plans to discontinue U.S. […]","og_url":"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/","og_site_name":"Asthma and Allergy Foundation of America","article_published_time":"2024-04-15T18:45:32+00:00","article_modified_time":"2024-06-25T21:23:46+00:00","og_image":[{"width":1080,"height":1080,"url":"https:\/\/aafa.org\/wp-content\/uploads\/2024\/04\/teva-digihaler-discontinuation-SM-jpg.webp","type":"image\/jpeg"}],"author":"Asthma and Allergy Foundation of America (AAFA)","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Asthma and Allergy Foundation of America (AAFA)","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/#article","isPartOf":{"@id":"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/"},"author":{"name":"Asthma and Allergy Foundation of America (AAFA)","@id":"https:\/\/aafa.org\/#\/schema\/person\/cf1763f0a1e69f5fa901f01d8e07c19b"},"headline":"Digihaler Discontinuation May Cause Another Disruption in Care for People with Asthma","datePublished":"2024-04-15T18:45:32+00:00","dateModified":"2024-06-25T21:23:46+00:00","mainEntityOfPage":{"@id":"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/"},"wordCount":1059,"image":{"@id":"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/#primaryimage"},"thumbnailUrl":"https:\/\/aafa.org\/wp-content\/uploads\/2024\/04\/teva-digihaler-discontinuation-SM-jpg.webp","articleSection":["Press Release"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/","url":"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/","name":"Digihaler Discontinuation May Cause Another Disruption in Care for People with Asthma - Asthma and Allergy Foundation of America","isPartOf":{"@id":"https:\/\/aafa.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/#primaryimage"},"image":{"@id":"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/#primaryimage"},"thumbnailUrl":"https:\/\/aafa.org\/wp-content\/uploads\/2024\/04\/teva-digihaler-discontinuation-SM-jpg.webp","datePublished":"2024-04-15T18:45:32+00:00","dateModified":"2024-06-25T21:23:46+00:00","author":{"@id":"https:\/\/aafa.org\/#\/schema\/person\/cf1763f0a1e69f5fa901f01d8e07c19b"},"breadcrumb":{"@id":"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/#primaryimage","url":"https:\/\/aafa.org\/wp-content\/uploads\/2024\/04\/teva-digihaler-discontinuation-SM-jpg.webp","contentUrl":"https:\/\/aafa.org\/wp-content\/uploads\/2024\/04\/teva-digihaler-discontinuation-SM-jpg.webp","width":1080,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/aafa.org\/digihaler-discontinuation-may-cause-another-disruption-in-care-for-people-with-asthma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Press Release","item":"https:\/\/aafa.org\/news\/press-releases\/"},{"@type":"ListItem","position":2,"name":"Digihaler Discontinuation May Cause Another Disruption in Care for People with Asthma"}]},{"@type":"WebSite","@id":"https:\/\/aafa.org\/#website","url":"https:\/\/aafa.org\/","name":"Asthma and Allergy Foundation of America","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aafa.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/aafa.org\/#\/schema\/person\/cf1763f0a1e69f5fa901f01d8e07c19b","name":"Asthma and Allergy Foundation of America (AAFA)","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f319ac743f2ee5f4b0bb04496f0f4185a171b28b586bf69b30337376fbd43e25?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f319ac743f2ee5f4b0bb04496f0f4185a171b28b586bf69b30337376fbd43e25?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f319ac743f2ee5f4b0bb04496f0f4185a171b28b586bf69b30337376fbd43e25?s=96&d=mm&r=g","caption":"Asthma and Allergy Foundation of America (AAFA)"}}]}},"_links":{"self":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/posts\/19657","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/comments?post=19657"}],"version-history":[{"count":7,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/posts\/19657\/revisions"}],"predecessor-version":[{"id":19667,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/posts\/19657\/revisions\/19667"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/media\/19659"}],"wp:attachment":[{"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/media?parent=19657"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/categories?post=19657"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aafa.org\/wp-json\/wp\/v2\/tags?post=19657"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}